Cargando…
Usefulness of (11)C-Methionine Positron Emission Tomography for Monitoring of Treatment Response and Recurrence in a Glioblastoma Patient on Bevacizumab Therapy: A Case Report
Recently developed molecular targeted therapies such as bevacizumab (BEV; Avastin) therapy have therapeutic efficacy for glioblastoma. However, it is difficult to distinguish between a tumor response and nonenhancing tumor progression with conventional magnetic resonance imaging (MRI) after BEV admi...
Autores principales: | Nakano, Tomoyuki, Tamura, Kaoru, Tanaka, Yoji, Inaji, Motoki, Hayashi, Shihori, Kobayashi, Daisuke, Nariai, Tadashi, Toyohara, Jun, Ishii, Kenji, Maehara, Taketoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062727/ https://www.ncbi.nlm.nih.gov/pubmed/30057540 http://dx.doi.org/10.1159/000490457 |
Ejemplares similares
-
NI-10 T2/FLAIR mismatch sign and methionine PET uptake in grade II and III gliomas
por: Ebiko, Yusuke, et al.
Publicado: (2020) -
NI-8 Molecular diagnostic prediction combining T2-FLAIR mismatch sign, calcification, and methionine PET in grade II and III gliomas
por: Ebiko, Yusuke, et al.
Publicado: (2021) -
NI-1 METHYLTHIOADENOSINE PHOSPHOLYLASE STATUS CORRELATES WITH PROGNOSIS AND METHIONINE UPTAKE IN IDH MUTANT ASTROCYTOMA
por: Yamamura, Toshihiro, et al.
Publicado: (2022) -
NI-10 Reclassification of diffuse gliomas based on molecular diagnosis -evaluation of methionine uptake and treatment outcome-
por: Tamura, Kaoru, et al.
Publicado: (2021) -
Intravoxel incoherent motion perfusion in patients with Moyamoya disease: comparison with (15)O-gas positron emission tomography
por: Hara, Shoko, et al.
Publicado: (2019)